Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-CEPHALEXIN TEVA CANADA LIMITED Actual shortage 500MG New Report 2025-12-11 274112
TEVA-SERTRALINE TEVA CANADA LIMITED Actual shortage 100MG New Report 2025-12-11 274109
TEVA-LISINOPRIL/HCTZ (TYPE Z) TEVA CANADA LIMITED Actual shortage 12.5MG 10MG New Report 2025-12-11 274106
TEVA-MYCOPHENOLATE TEVA CANADA LIMITED Actual shortage 500MG New Report 2025-12-11 274103
TEVA-SERTRALINE TEVA CANADA LIMITED Actual shortage 50MG Updated Report 2025-12-11 273277
SEASONIQUE TEVA CANADA LIMITED Resolved 0.15MG 0.01MG 0.03MG Updated Report 2025-12-11 269687
TEVA-NAPROXEN EC TEVA CANADA LIMITED Resolved 500MG Updated Report 2025-12-11 259011
AMPICILLIN SODIUM FOR INJECTION, USP TEVA CANADA LIMITED Resolved 1G Updated Report 2025-12-11 259685
ACT ESCITALOPRAM ODT TEVA CANADA LIMITED Resolved 10MG Updated Report 2025-12-11 263166
TEVA-RAMIPRIL TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2025-12-11 271832

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TRUSOPT ELVIUM LIFE SCIENCES Discontinued 2% Updated Report 2025-12-10 267941
FIASP NOVO NORDISK CANADA INC Discontinued 100UNIT Updated Report 2025-12-08 240240
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 500MG Updated Report 2025-12-06 273434
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 750MG Updated Report 2025-12-06 273437
NAT-OMEPRAZOLE DR NATCO PHARMA (CANADA) INC Discontinued 20MG Updated Report 2025-12-06 273440
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 25MG Updated Report 2025-12-06 273482
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 100MG Updated Report 2025-12-06 273489
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 200MG Updated Report 2025-12-06 273496
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 300MG Updated Report 2025-12-06 273501
NAT-DONEPEZIL NATCO PHARMA (CANADA) INC Discontinued 5MG Updated Report 2025-12-06 273383